Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ritalin for Balance and Walking in Multiple Sclerosis
NCT01896700Phase 3Completed
- Sponsor
- Oregon Health & Science University
- Start
- Jul 2013
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylphenidate in multiple sclerosis (MS), sponsored by Oregon Health & Science University. Started Jul 2013; status: completed.
02
Drugs
methylphenidate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01896700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01896700.